PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that a respiratory patient monitoring program ...
Via an integration with Teva Pharmaceuticals, the new module will leverage digital therapeutics to improve outcomes for patients with respiratory diseases Over 500 million people globally suffer from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results